Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EHD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDIPT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UMPS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EFNB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FTL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IPO13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPP3CC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BOLA2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRP63 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTSO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RHBDD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KATNB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HAUS5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATPIF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBM14-RBM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR6805 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIOBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BZW2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TEF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on